» Articles » PMID: 30713482

Highlight Report: Toxicogenomics Atlas of Rat Hepatotoxicants

Overview
Journal EXCLI J
Specialty Biology
Date 2019 Feb 5
PMID 30713482
Authors
Affiliations
Soon will be listed here.
References
1.
Stemmer K, Ellinger-Ziegelbauer H, Ahr H, Dietrich D . Carcinogen-specific gene expression profiles in short-term treated Eker and wild-type rats indicative of pathways involved in renal tumorigenesis. Cancer Res. 2007; 67(9):4052-68. DOI: 10.1158/0008-5472.CAN-06-3587. View

2.
Ellinger-Ziegelbauer H, Adler M, Amberg A, Brandenburg A, Callanan J, Connor S . The enhanced value of combining conventional and "omics" analyses in early assessment of drug-induced hepatobiliary injury. Toxicol Appl Pharmacol. 2010; 252(2):97-111. DOI: 10.1016/j.taap.2010.09.022. View

3.
Godoy P, Hewitt N, Albrecht U, Andersen M, Ansari N, Bhattacharya S . Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol. 2013; 87(8):1315-530. PMC: 3753504. DOI: 10.1007/s00204-013-1078-5. View

4.
Waldmann T, Rempel E, Balmer N, Konig A, Kolde R, Gaspar J . Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. Chem Res Toxicol. 2014; 27(3):408-20. PMC: 3958134. DOI: 10.1021/tx400402j. View

5.
Balmer N, Klima S, Rempel E, Ivanova V, Kolde R, Weng M . From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014; 88(7):1451-68. PMC: 4067541. DOI: 10.1007/s00204-014-1279-6. View